- Min.Order :1 Gram
- Purity: > 95%
- Payment Terms : L/C
Keywords
(1S)-1-(2-Chlorophenyl)-1,2-ethanediol 2-Carbamate JNJ 10234094 RWJ 333369
Quick Details
- Appearance:White Solid
- Application:Carisbamate (YKP 509, proposed trade name Comfyde) is an experimental anticonvulsant drug under development by Johnson & Johnson Pharmaceutical Research and Development. In 1998, the compound was in-l
- PackAge:inquiry
- ProductionCapacity:10|Kilogram|Month
- Storage:10kg
- Transportation:inquiry
Superiority:
BOC Sciences is committed to supplying cost-effective products and services. We provide Carisbamate (RWJ-333369). Carisbamate (YKP 509, proposed trade name Comfyde) is an experimental anticonvulsant drug under development by Johnson & Johnson Pharmaceutical Research and Development. In 1998, the compound was in-licensed from SK Corp. (currently Life Science Business Division of SK Holdings), a South Korean company. A phase II clinical trial in the treatment of partial seizures demonstrated that the compound has efficacy in the treatment of partial seizures and a good safety profile. Since late 2006, the compound has been undergoing a large multicenter phase III clinical trial for the treatment of partial seizures. Its mechanism of action is unknown. More information please visit: www.bocsci.com/carisbamate-rwj-333369-cas-194085-75-1-item-468174.html
Details:
BOC Sciences is committed to supplying cost-effective products and services. We provide Carisbamate (RWJ-333369). Carisbamate (YKP 509, proposed trade name Comfyde) is an experimental anticonvulsant drug under development by Johnson & Johnson Pharmaceutical Research and Development. In 1998, the compound was in-licensed from SK Corp. (currently Life Science Business Division of SK Holdings), a South Korean company. A phase II clinical trial in the treatment of partial seizures demonstrated that the compound has efficacy in the treatment of partial seizures and a good safety profile. Since late 2006, the compound has been undergoing a large multicenter phase III clinical trial for the treatment of partial seizures. Its mechanism of action is unknown. More information please visit: www.bocsci.com/carisbamate-rwj-333369-cas-194085-75-1-item-468174.html
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View